MONTREAL, Aug. 29, 2014 /CNW Telbec/ - DMD Digital Health Connections Group Inc. (formerly known as Aptilon Corporation) ("DMD" or the "Company"), today announces that each of the Autorité des Marchés Financiers, the Ontario Securities Commission, the Alberta Securities Commission, the British Columbia Securities Commission and the Manitoba Securities Commission has issued an order revoking the cease-trade orders (the "CTOs") that they imposed on the Company in 2012 or 2013. All of the CTOs will be lifted as of August 28, 2014. The Company has filed all outstanding financial statements and other required documents.
The Company has made an application for reinstatement of its listing on the TSX Venture Exchange.
On behalf of the Board of Directors of DMD Digital Health Connections Group Inc.
About DMD Digital Health Connections Group Inc.
DMD enables pharmaceutical, pharmaceutical marketing companies, digital advertising agencies and medical device companies to effectively reach, message, connect and interact with US physicians and healthcare professionals via multiple access channels. Its innovative service offerings provide targeted impressions and interactions through permission-based email, targeted on-line ad-serving, and mobile app advertising channels. Top pharmaceutical companies, agencies and respected healthcare organizations have adopted DMD's solutions to target, engage and interact with leading healthcare practitioners. For more information, visit www.dmdconnects.com .
This news release contains forward-looking information. These statements relate to future events or future performance and reflect management's current expectations and assumptions. Such forward-looking statements reflect management's current beliefs and are based on information currently available to management of DMD. A number of factors could cause actual events, performance or results to differ materially from the events performance and results discussed in the forward-looking statements. These forward-looking statements are made as of the date hereof and DMD does not assume any obligation to update or revise them to reflect new events or circumstances.
Neither NEX, the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: DMD Digital Health Connections Group Inc.
For further information: André Charron, CFO, DMD Digital Health Connections Group Inc., 514-769-5858, ACharron@dmdconnects.com